1. Home
  2. ESPR vs BFS Comparison

ESPR vs BFS Comparison

Compare ESPR & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.89

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

BFS

Saul Centers Inc.

HOLD

Current Price

$31.62

Market Cap

759.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
BFS
Founded
2008
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
898.5M
759.2M
IPO Year
2013
1993

Fundamental Metrics

Financial Performance
Metric
ESPR
BFS
Price
$3.89
$31.62
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$6.67
N/A
AVG Volume (30 Days)
5.3M
75.0K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
7.48%
EPS Growth
N/A
N/A
EPS
N/A
1.14
Revenue
$303,802,000.00
$282,618,000.00
Revenue This Year
$26.11
$8.14
Revenue Next Year
N/A
$5.75
P/E Ratio
N/A
$27.66
Revenue Growth
2.83
5.61
52 Week Low
$0.69
$29.16
52 Week High
$4.13
$39.15

Technical Indicators

Market Signals
Indicator
ESPR
BFS
Relative Strength Index (RSI) 55.97 54.60
Support Level $3.87 $31.00
Resistance Level $4.05 $32.37
Average True Range (ATR) 0.20 0.57
MACD -0.02 -0.01
Stochastic Oscillator 50.00 54.79

Price Performance

Historical Comparison
ESPR
BFS

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

Share on Social Networks: